What Does the Sale of Progyny Shares by the CFO Mean for Investors?
Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC filings.
What Does the Sale of Progyny Shares by the CFO Mean for Investors?
Overview
Mark S. Livingston, Chief Financial Officer of Progyny (NASDAQ:PGNY), reported the sale of 8,275 shares of common stock in an open-market transaction on May 20, 2026, as disclosed in an SEC Form 4 filing.
Transaction value based on SEC Form 4 reported price ($25.50); post-transaction value based on May 20, 2026 trade-date close price.
Details
* 1-year performance metrics are calculated using May 20th, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
